Literature DB >> 15976538

Outcomes of laparoscopic treatment for endometrial cancer.

Javier F Magrina1.   

Abstract

PURPOSE OF REVIEW: Laparoscopy has become the standard approach for the surgical management of a variety of benign gynecological conditions. Numerous studies have reported their findings on the laparoscopic approach for the treatment of patients with endometrial cancer. It is timely and relevant to provide a review of these findings. RECENT
FINDINGS: Comparison analysis of recurrence and survival rates for patients treated by laparoscopy and laparotomy have found similar results. A similar or reduced cost is noted for the laparoscopic approach. Numerous patient advantages are indicated for the laparoscopic approach. This information is detailed in this review.
SUMMARY: The open abdominal approach is an alternative to laparoscopy for the surgical treatment of patients with early endometrial cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15976538     DOI: 10.1097/01.gco.0000175350.18308.73

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  11 in total

1.  Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer.

Authors:  Tae Wook Kong; Kyung Mi Lee; Ji Yoon Cheong; Woo Young Kim; Suk-Joon Chang; Seung-Chul Yoo; Jong-Hyuck Yoon; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

2.  Total laparoendoscopic single-site surgery (LESS) hysterectomy in low-risk early endometrial cancer: a pilot study.

Authors:  Francesco Fanfani; Cristiano Rossitto; Maria Lucia Gagliardi; Valerio Gallotta; Salvatore Gueli Alletti; Giovanni Scambia; Anna Fagotti
Journal:  Surg Endosc       Date:  2011-07-26       Impact factor: 4.584

3.  Evaluation of the learning curve of total robotic hysterectomy with or without lymphadenectomy for a gynecologic oncology service.

Authors:  Rodney P Rocconi; Courtney Meredith; Michael A Finan
Journal:  J Robot Surg       Date:  2011-03-09

4.  Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.

Authors:  Stella Capriglione; Francesco Plotti; Andrea Miranda; Roberto Ricciardi; Giuseppe Scaletta; Alessia Aloisi; Federica Guzzo; Roberto Montera; Roberto Angioli
Journal:  Tumour Biol       Date:  2015-01-11

5.  Peri-operative and survival outcomes analysis of patients with endometrial cancer managed by three surgical approaches: a long-term Bulgarian experience.

Authors:  Slavcho T Tomov; Grigor A Gorchev; Desislava K Kiprova; Aleksandar D Lyubenov; Nadezhda H Hinkova; Vesela D Tomova; Zornitsa V Gorcheva; Sarfraz Ahmad
Journal:  J Robot Surg       Date:  2022-02-10

6.  Laparoscopic versus abdominal hysterectomy for endometrial cancer: comparison of patient outcomes.

Authors:  Gary S Leiserowitz; Guibo Xing; Arti Parikh-Patel; Rosemary Cress; Alireza Abidi; Anne O Rodriguez; John L Dalrymple
Journal:  Int J Gynecol Cancer       Date:  2009-11       Impact factor: 3.437

7.  Robotic surgical management of endometrial cancer in octogenarians and nonagenarians: analysis of perioperative outcomes and review of the literature.

Authors:  M Patrick Lowe; Saurabh Kumar; Peter R Johnson; Scott A Kamelle; Donald H Chamberlain; Todd D Tillmanns
Journal:  J Robot Surg       Date:  2010-06-11

8.  A comparison of robot-assisted and traditional radical hysterectomy for early-stage cervical cancer.

Authors:  M Patrick Lowe; Anna V Hoekstra; Arati Jairam-Thodla; Diljeet K Singh; Barbara M Buttin; John R Lurain; Julian C Schink
Journal:  J Robot Surg       Date:  2009-02-27

9.  Feasibility, safety, and cost outcomes of laparoscopic management of early endometrial and cervical malignancy.

Authors:  Georgios E Hilaris; Thomas Tsoubis; Vasilios Konstantopoulos; Kitty Pavlakis
Journal:  JSLS       Date:  2009 Oct-Dec       Impact factor: 2.172

Review 10.  Robotic surgery for cervical cancer.

Authors:  Javier F Magrina; Vanna L Zanagnolo
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.